Stuart Rich - Net Worth and Insider Trading

Stuart Rich Net Worth

The estimated net worth of Stuart Rich is at least $173,486 dollars as of 2026-08-04. Stuart Rich is the Chief Medical Officer of Tenax Therapeutics Inc and owns about 12,654 shares of Tenax Therapeutics Inc (TENX) stock worth over $173,486. Details can be seen in Stuart Rich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stuart Rich has not made any transactions after 2025-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Stuart Rich

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Stuart Rich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stuart Rich owns 1 companies in total, including Tenax Therapeutics Inc (TENX) .

Click here to see the complete history of Stuart Rich’s form 4 insider trades.

Insider Ownership Summary of Stuart Rich

Ticker Company Transaction Date Type of Owner
TENX Tenax Therapeutics Inc 2025-12-09 Chief Medical Officer

Stuart Rich Latest Holdings Summary

Stuart Rich currently owns a total of 1 stock. Stuart Rich owns 12,654 shares of Tenax Therapeutics Inc (TENX) as of December 9, 2025, with a value of $173,486.

Latest Holdings of Stuart Rich

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TENX Tenax Therapeutics Inc 2025-12-09 12,654 13.71 173,486

Holding Weightings of Stuart Rich


Stuart Rich Form 4 Trading Tracker

According to the SEC Form 4 filings, Stuart Rich has made a total of 2 transactions in Tenax Therapeutics Inc (TENX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Tenax Therapeutics Inc is the acquisition of 5,000 shares on December 9, 2025, which cost Stuart Rich around $50,800.

Insider Trading History of Stuart Rich

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stuart Rich Trading Performance

GuruFocus tracks the stock performance after each of Stuart Rich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stuart Rich is 20.51%. GuruFocus also compares Stuart Rich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stuart Rich within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stuart Rich's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stuart Rich

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 26.61 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 25.68 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Stuart Rich owns.
View TENX Analysis

Stuart Rich Ownership Network

Ownership Network List of Stuart Rich

No Data

Ownership Network Relation of Stuart Rich

Insider Network Chart


Stuart Rich Owned Company Details

What does Tenax Therapeutics Inc do?

Who are the key executives at Tenax Therapeutics Inc?

Stuart Rich is the Chief Medical Officer of Tenax Therapeutics Inc. Other key executives at Tenax Therapeutics Inc include Chief Financial Officer Staab Thomas R Ii , director & CEO Chrisopher Thomas Giordano , and Interim CFO Thomas Mcgauley .

Tenax Therapeutics Inc (TENX) Insider Trades Summary

Over the past 18 months, Stuart Rich made 2 insider transaction in Tenax Therapeutics Inc (TENX) with a net purchase of 10,000. Other recent insider transactions involving Tenax Therapeutics Inc (TENX) include a net purchase of 3,986 shares made by June Sherie Almenoff , a net purchase of 8,000 shares made by Thomas Mcgauley , and a net purchase of 2,605 shares made by Chrisopher Thomas Giordano .

In summary, during the past 3 months, insiders sold 0 shares of Tenax Therapeutics Inc (TENX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenax Therapeutics Inc (TENX) were sold and 24,591 shares were bought by its insiders, resulting in a net purchase of 24,591 shares.

Tenax Therapeutics Inc (TENX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tenax Therapeutics Inc Insider Transactions

No Available Data

Stuart Rich Mailing Address

Above is the net worth, insider trading, and ownership report for Stuart Rich. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Stuart Rich's mailing address is: Morrisville Nc 27560.